Roivant Sciences Ltd. ($ROIV)
Filing Information
| Accession Number | 0001635088-26-000071 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
600,000
Total Value
$7,401,267.64
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President & Immunovant CEO | Common Shares | โ | Jun 24, 2026 | Exercise/Conversion | 200,000 | $3.85 | $770,000.00 | 1,813,063 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Jun 24, 2026 | Sale | 153,766 | $33.05 | $5,081,966.30 | 1,659,297 | Direct | โ | View Details | |
President & Immunovant CEO | Common Shares | โ | Jun 24, 2026 | Sale | 46,234 | $33.51 | $1,549,301.34 | 1,613,063 | Direct | โ | View Details | |
President & Immunovant CEO | Stock Option (Right to Buy) | Derivative | Jun 24, 2026 | Exercise/Conversion | 200,000 | $0.00 | $0.00 | 4,244,834 | Direct | โ | View Details |